Howland RH, 2016-10-01: A history of methylene blue in psychiatry. It states that methylene blue was used to treat psychotic patients about fifty years before chlorpromazine, which supports that part of the claim.
Although chlorpromazine is heralded as the first antipsychotic drug used in psychiatry, methylene blue is a phenothiazine drug that had been used to treat psychotic patients half a century earlier.
Howland RH, 2016-10-01: A history of methylene blue in psychiatry. It states that methylene blue was used to treat psychotic patients about fifty years before chlorpromazine, which supports that part of the claim. Study type: historical review. Country: USA (author affiliation not a trial centre). Cites the 1899 Italian report by Bodoni on the sedative action of methylene blue in psychoses (Clin Med Ital 1899;24:217-222), which the review 'Cellular and molecular actions of Methylene Blue in the nervous system' also cites. No study data. Also filed as MTA-17 (claims C16, C5). Study type: review.
